Laser beats shockwave for neck pain in new study

NCT ID NCT07593781

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two non-invasive treatments for neck muscle pain in 50 adults. One group received shockwave therapy, the other low-level laser therapy, both once a week for three weeks. Laser therapy led to greater pain reduction and improved neck movement at the three-week mark.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
radial extracorporeal shockwave therapy and low-level laser therapy
What this could lead to
If this works, it could help doctors choose the best non-invasive treatment for neck muscle pain.
What could go wrong
This was a small, completed trial with only 50 participants. Results may not apply to everyone, and longer-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Oct 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 59 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * men and women * aged 18 to 59 years old * sedentary activity level * active MTrP on the upper trapezius muscle * moderate pain with an NRS pain score of 4-7 * restriction of ROM * CVA angle of ≤ 50° * All agreed to participate in this study with informed consent. Exclusion Criteria: * patients who were unable to complete the assessment or communicate adequately based on the Indonesian version of Montreal Cognitive Assessment (MoCA-Ina) * experiencing neck pain caused by radicular syndrome proven with the Spurling test, distraction test and Adson test. * history of malignancy * history of blood clotting disorder * receiving anticoagulant therapy * in a emergency state (e.g., loss of consciousness, shortness of breath, active bleeding, seizures, or hyperpyrexia) * pregnant * participants with pacemaker * participants undergoing other treatments (manual therapy, massage, acupuncture, dry needling, or other rehabilitation modalities) for neck pain in the previous two weeks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Extracorporeal shockwave therapy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universitas Indonesia, Cipto Mangunkusumo General Hospital

    Jakarta Pusat, DKI Jakarta, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.